Oasmia Pharmaceutical Ab (OASM) Return on Equity ROE from the fourth quarter 2018 to fourth quarter and annually, average high and low, overall ranking from Apr 30 2018 to - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oasmia Pharmaceutical Ab  (OASM)

Oasmia Pharmaceutical Ab's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Oasmia Pharmaceutical Ab in the fourth quarter 2018?
Due to the lack of equity, it was not possible to calculate Oasmia Pharmaceutical Ab's return on equity (ROE) in its fourth quarter 2018

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Apr 30 2018)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -118 0 0 0 0
Return On Equity (TTM) - - - 0 % 0 %
OASM's Total Ranking # # # # #
Equity (TTM) in Millions -118 -118 -118 -118 34
Seq. Equity Change - - - - -16.57 %
Seq. Net Income Change - - - - -

Back to OASM Management Effectiveness >> OASM's 5 Years Annual ROE >> Compare OASM ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





OASM Annual Return On Equity (Apr 30 2018)
2018



Total Equity in Millions -118 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -118 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to OASM Management Effectiveness >> OASM's 5 Years Annual ROE >> Compare OASM ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
OASM's' Return on Equity at Yahoo Finance
OASM's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for OASM's Competitors
Subscribers only: Roe for Oasmia Pharmaceutical Ab's Suppliers
Subscribers only: Return On Equity for OASM's Customers




Companies with similar Return On Equity at Apr 30 2018, within Healthcare Sector ROE
Palatin Technologies Inc   258.01 %
Elite Pharmaceuticals Inc   240.11 %
Gadsden Properties, Inc.  222.54 %
Ontrak Inc   163.73 %
Tuhura Biosciences Inc   125.05 %
Lifemd Inc   120.74 %
Abbvie Inc   119.57 %
Corcept Therapeutics Inc  101.81 %
Celgene Corp  90.60 %
Capricor Therapeutics inc   89.01 %
Exelixis Inc   75.53 %
Qc Technologies Inc   74.19 %
Mettler toledo International Inc   72.36 %
Oramed Pharmaceuticals Inc  58.15 %
Tenax Therapeutics Inc   56.97 %
Lisata Therapeutics Inc   53.40 %
Zoetis Inc   51.71 %
Mimedx Group Inc   51.44 %
Avalo Therapeutics Inc   51.13 %
Plx Pharma Inc   48.05 %
Prestige Consumer Healthcare Inc   47.56 %
Cutera Inc   45.61 %
Halozyme Therapeutics Inc   45.30 %
Viskase Holdings inc   42.93 %
Pfizer Inc  38.13 %
Jrsis Health Care Corp  37.75 %
Luna Innovations Inc  36.53 %
3m Company  35.68 %
Phibro Animal Health Corporation  35.38 %
Ligand Pharmaceuticals Incorporated  34.34 %

Date modified: 2026-09-18T13:11:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.